Director Sells VIAV 3,384 Shares for $63,484

Viavi Solutions Director Richard John Burns executed an open-market sale of 3,384 shares on Dec. 10, 2025 (50% of his direct holdings, down from 6,768 to 3,384 shares) under a pre-established Rule 10b5-1 plan; the Form 4 lists the trade at $18.76 for a reported transaction value of $63,483.84 and post-trade direct ownership of 0.0015% of outstanding shares. Viavi reports TTM revenue of $1.15 billion and net income of $15.20 million, with a recent recovery in profitability (trailing P/E ~292, forward P/E ~29) and strong recent share performance driven by AI-related data‑center demand; the trade is small relative to market cap and is unlikely to be materially market-moving.

Analysis

Market structure: The insider sale (3,384 shares, ~$63k) is immaterial to float (post-trade direct = 0.0015%) so immediate supply shock is nil; primary winners remain data‑center builders, optical component suppliers and Viavi (VIAV) if AI-driven capex sustains, while legacy low-growth testers may lose relative funding. Pricing power for Viavi is improving — revenue $1.15B and net income $15.2M with a forward P/E ~29 — implying the market is pricing growth; if quarterly bookings accelerate 10–20% y/y this could support a re-rating to mid‑30s P/E.

Risk assessment: Tail risks include an AI capex slowdown (20–40% downside to bookings), export controls on photonics, or a large customer contract loss; these are low probability but 1–2 quarter shocks could compress forward P/E back to <20. Immediate impact (days) is negligible; short term (weeks–months) watch for post-earnings guidance and backlog cadence; long term (quarters–years) depends on sustained fiber/optical spending and margin recovery. Hidden dependencies: customer concentration and backlog timing — an outsized telecom order can swing quarterly revenue by >10%.

Trade implications: Direct play — establish a tactical long in VIAV (2–3% portfolio) on pullback to <$17 (≈10% downside) with stop at $14 and target $30 within 12 months (≈+56%). Options — buy Jan 2027 $25 calls as a capped-risk asymmetric bet (position size ≤0.5% portfolio) or sell 3–4 week covered calls to monetize elevated IV after rallies. Pair trade — long VIAV vs short KEYS (Keysight) 1:0.6 if optical/test exposure outperforms general instrumentation over 6–12 months.

Contrarian angles: Consensus frames this as insider profit‑taking, but the volume and 10b5‑1 plan show pre‑set disposition — not a signal of private negative information; a modest selloff would likely be overdone. Historical parallels: post‑spin recovery cycles (JDSU lineage) show multi‑year rebounds when secular demand returns; unintended consequence risk is aggregation of 10b5‑1 sales creating steady supply — monitor cumulative insider filings and large block trades over rolling 30‑60 days.

Key Decisions for Investors

• Establish a 2–3% long position in VIAV on weakness: initiate between $17–$19 (current ~ $19), set hard stop at $14, and target $30 within 12 months (risk/reward ~2.5x).
• Buy Jan 2027 VIAV $25 calls sized ≤0.5% of portfolio as an asymmetric bet on continued AI/data‑center optical capex; exit or roll if VIAV < $16 at any point.
• Implement a relative‑value pair: long VIAV (1.0x) vs short KEYS (0.6x) size to express optical/test outperformance over 6–12 months; rebalance if divergence >15% in 90 days.
• If forward guidance misses by >5% on revenue or bookings, reduce VIAV exposure by 50% and buy protection (put spread e.g., buy $15 put / sell $12 put) to cap drawdown through next earnings cycle.